pubmed-article:12838128 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12838128 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
pubmed-article:12838128 | lifeskim:mentions | umls-concept:C0023216 | lld:lifeskim |
pubmed-article:12838128 | lifeskim:mentions | umls-concept:C0024203 | lld:lifeskim |
pubmed-article:12838128 | lifeskim:mentions | umls-concept:C0877794 | lld:lifeskim |
pubmed-article:12838128 | lifeskim:mentions | umls-concept:C1446409 | lld:lifeskim |
pubmed-article:12838128 | lifeskim:mentions | umls-concept:C0242382 | lld:lifeskim |
pubmed-article:12838128 | lifeskim:mentions | umls-concept:C0205124 | lld:lifeskim |
pubmed-article:12838128 | lifeskim:mentions | umls-concept:C0950580 | lld:lifeskim |
pubmed-article:12838128 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:12838128 | pubmed:dateCreated | 2003-7-2 | lld:pubmed |
pubmed-article:12838128 | pubmed:abstractText | The purpose of this study was to evaluate retrospectively the value of a subsequent superficial femoral lymph node dissection for patients with early melanoma of the lower extremity after a positive sentinel lymphadenectomy. During a 6-year period at the H. Lee Moffitt Cancer Center & Research Institute, 16 consecutive patients with clinical stage I or stage II melanoma of the lower extremity underwent subsequent superficial femoral lymph node dissections after positive sentinel lymphadenectomies and wide local excisions of the primary lesions. Fifteen patients (94%) were found to have no additional positive lymph nodes from their superficial femoral lymph node dissection specimens. In contrast, only 1 patient (6%) with a thick primary lesion (7.5 mm) was found to have one additional positive lymph node on a subsequent superficial femoral lymph node dissection. No patients developed any regional nodal recurrences during a mean follow-up of 31.1 months (range, 3-80 months). This preliminary report suggests that the majority of the time the sentinel lymph node may be the only site of regional microscopic nodal disease and that a subsequent superficial femoral lymph node dissection may not be necessary in patients with early melanoma of the lower extremity after a positive sentinel lymphadenectomy. However, whether the sentinel lymphadenectomy can be used solely as a regional surgical treatment for this subgroup of patients still warrants further evaluation. | lld:pubmed |
pubmed-article:12838128 | pubmed:language | eng | lld:pubmed |
pubmed-article:12838128 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12838128 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12838128 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12838128 | pubmed:month | Jul | lld:pubmed |
pubmed-article:12838128 | pubmed:issn | 0148-7043 | lld:pubmed |
pubmed-article:12838128 | pubmed:author | pubmed-author:ReintgenDougl... | lld:pubmed |
pubmed-article:12838128 | pubmed:author | pubmed-author:ShonsAlan RAR | lld:pubmed |
pubmed-article:12838128 | pubmed:author | pubmed-author:PuLee L QLL | lld:pubmed |
pubmed-article:12838128 | pubmed:author | pubmed-author:WellsKaren... | lld:pubmed |
pubmed-article:12838128 | pubmed:author | pubmed-author:CruseC... | lld:pubmed |
pubmed-article:12838128 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12838128 | pubmed:volume | 51 | lld:pubmed |
pubmed-article:12838128 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12838128 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12838128 | pubmed:pagination | 69-76 | lld:pubmed |
pubmed-article:12838128 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:meshHeading | pubmed-meshheading:12838128... | lld:pubmed |
pubmed-article:12838128 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12838128 | pubmed:articleTitle | Superficial femoral lymph node dissection after positive sentinel lymphadenectomy for early-stage melanoma of the lower extremity. | lld:pubmed |
pubmed-article:12838128 | pubmed:affiliation | Division of Plastic Surgery, University of South Florida and the Cutaneous Oncology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. | lld:pubmed |
pubmed-article:12838128 | pubmed:publicationType | Journal Article | lld:pubmed |